Enhanced cancer immunotherapy via synergistic action of NO-Donor nanoparticles (NanoARG) and PD-1 antibody
This study explores the synergistic potential of PEG-b-P(L-Arg)-based polyion complex micelles (NanoARGs) combined with an immune checkpoint inhibitor (PD-1 antibody) for cancer immunotherapy. Comprehensive experiments, including micelle preparation, in vivo anti-tumor activity evaluation, nitric ox...
Saved in:
Main Authors: | Mei Ting, Xin Zhang, Xiaolu Hou, Yukio Nagasaki |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-07-01
|
Series: | Science and Technology of Advanced Materials |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/14686996.2025.2538430 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunotherapy of cancer tumors with inhibition of PD-1 membrane protein and its ligands interaction
by: A. V. Chetveryakov, et al.
Published: (2021-10-01) -
Visualization of PD-L1-positive and PD-1-positive immune cell contact in the breast cancer microenvironment
by: A. Yu. Kalinchuk, et al.
Published: (2024-03-01) -
Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy
by: Wuyuan Liao, et al.
Published: (2025-07-01) -
ROS/Enzyme Dual-Responsive Drug Delivery System for Targeted Colorectal Cancer Therapy: Synergistic Chemotherapy, Anti-Inflammatory, and Gut Microbiota Modulation
by: Xin Zhang, et al.
Published: (2025-07-01) -
Mapping the immunological landscape and emerging immunotherapeutic strategies in cervical cancer: a comprehensive review
by: Xinyi Zhang, et al.
Published: (2025-07-01)